Bank of America’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-68,190
| Closed | -$17.4K | – | 7126 |
|
2023
Q1 | $17.4K | Buy |
68,190
+18,861
| +38% | +$4.81K | ﹤0.01% | 5974 |
|
2022
Q4 | $58.2K | Buy |
49,329
+43,055
| +686% | +$50.8K | ﹤0.01% | 5655 |
|
2022
Q3 | $13K | Buy |
6,274
+6,266
| +78,325% | +$13K | ﹤0.01% | 6308 |
|
2022
Q2 | $0 | Sell |
8
-23,345
| -100% | – | ﹤0.01% | 7629 |
|
2022
Q1 | $118K | Buy |
+23,353
| New | +$118K | ﹤0.01% | 5996 |
|
2021
Q4 | – | Sell |
-61,132
| Closed | -$608K | – | 7794 |
|
2021
Q3 | $608K | Hold |
61,132
| – | – | ﹤0.01% | 4717 |
|
2021
Q2 | $604K | Buy |
+61,132
| New | +$604K | ﹤0.01% | 4575 |
|